Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 82
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05294536 | A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza® in Healthy Chinese Subjects | ||
| NCT07376200 | Single-ascending Dose Study of HEC-151 Injection | ||
| NCT04992858 | Ningetinib in Advanced NSCLC Skipping Mutations With MET Exon 14 Skipping Mutations | ||
| NCT03092102 | The Safety, Tolerability and Pharmacokinetic Study of HEC585 in Healthy Male and Female Subjects | ||
| NCT07771140 | A Phase I Clinical Trial to Evaluate HECN30227 Injection in Healthy Subjects and Subjects With Chronic Hepatitis B | ||
| NCT04536532 | Evaluation HEC121120 Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study | ||
| NCT03655873 | The Study of a Selective 5-ht6 Receptor Antagonist, HEC30654AcOH,in Healthy Subjects | ||
| NCT05127772 | A Clinical Trial of HEC93077 in Chinese Healthy Subjects and HUA Patients With Single or Multiple Dosing | ||
| NCT05427682 | A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Pyroglutamate Rongliflozin Capsules in Subjects With Mild and Moderate Liver Damage | ||
| NCT05391360 | Evaluation Freethiadine Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study | ||
| NCT07211165 | Clinical Study on the Mass Balance of Clifutinib | ||
| NCT05492630 | Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC73077 in Healthy Subjects | ||
| NCT05468346 | Study on the Body Mass Balance and Biotransformation of [14C]-HEC585 | ||
| NCT05048368 | Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic Function | ||
| NCT07099118 | A Safety, Tolerability, Pharmacokinetics/Pharmacodynamics Study of HEC169584 Capsules in Healthy Subjects | ||
| NCT03886688 | HEC53856 Phase 1 Study - Single and Multiple Oral Dosing in Healthy Volunteers | ||
| NCT04667429 | the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets | ||
| NCT05504876 | Pharmacokinetics of Midazolam When Co-administered With HEC74647 and HEC110114 | ||
| NCT07341672 | A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy Participants | ||
| NCT04827069 | A Clinical Trial to Evaluate Clifutinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia(AML) | ||
| NCT03502902 | The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects | ||
| NCT05060822 | Phase ll Study of HEC585 in Patients With IPF | ||
| NCT05057949 | A Study to Evaluate Drug-Drug Interaction of Larotinib With Itraconazole and Rifampin in Healthy Adult Participants | ||
| NCT05059743 | ADME Study of [14C]- Larotinib in Healthy Male Subjects | ||
| NCT03638076 | The Safety, Antiviral Activity, and Pharmacokinetics of Morphothiadine Mesilate Capsules | ||
| NCT03888092 | Z650 in Advanced Esophageal Squamous Cell Carcinoma With EGFR Over Expression or Gene Amplification | ||
| NCT05998304 | ADME Study of [14C] Yiqibuvir in Healthy Male Subjects | ||
| NCT05446233 | ADME Study of [14C] Antaitavir Hasophate in Healthy Male Subjects | ||
| NCT03663686 | The Safety, Tolerability and Pharmacokinetic Study of Litapiprant Tablets in Healthy Male and Female Subjects | ||
| NCT04422496 | The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Subjects | ||
| NCT04601610 | KN046 Combined With Ningatinib in the Treatment of Advanced Hepatocellular Carcinoma | ||
| NCT03758287 | Ningetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative | ||
| NCT03943251 | The Study of a Selective Serotonin Partial Agonist and Reuptake Inhibitors, HEC113995PA•H2O,in Healthy Subjects | ||
| NCT05383131 | To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy Volunteers | ||
| NCT04865458 | A Study to Evaluate the Tolerability, Safety, Pharmacokinetics of HEC89736 in Patients With Relapsed or Refractory B-cell Hematologic Malignancies | ||
| NCT03673696 | The Tolerability and Pharmacokinetics Study of HEC74647PA Capsule in Healthy Adult Subjects | ||
| NCT04925661 | HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia | ||
| NCT04552808 | To Evaluate the Pharmacokinetics and Safety of Yimitasvir Phosphate Capsules in Subjects With Moderate and Severe Liver Function Impairment and in Healthy Subjects | ||
| NCT04194242 | The Tolerability , Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Adult Subjects | ||
| NCT04625361 | Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC122505MsOH Tablets in Healthy Adult Subjects | ||
| NCT07102251 | A Study to Evaluate the Safety, Tolerability, PK/PD of HEC-007 Injection in Healthy and Overweight/Obese Subjects | ||
| NCT05451602 | HEC169096 in Participants With Advanced Solid Tumors | ||
| NCT03458481 | Phase 2 Study of Yimitasvir Phosphate Capsules | ||
| NCT05139719 | A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients | ||
| NCT04512170 | Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC585 in Healthy Male and Female Subjects | ||
| NCT04324372 | Clinical Study of HEC68498 in Patients With Advanced Refractory Solid Tumors | ||
| NCT05133882 | A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML | ||
| NCT05802862 | A Study of Insulin Degludec/Insulin Aspart Biosimilar (22011) Compared With Insulin Degludec/Insulin Aspart(Ryzodeg) in Participants With Type 2 Diabetes in China | ||
| NCT04982913 | Single Dose and Multiple Dose Safety, Tolerability, PK，and Food Effect Study，and Interaction With Oseltamivir Study of HEC116094 in Healthy Adult Subjects | ||
| NCT04202952 | The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC110114 Tablets in HCV-infected Subjects |
